In patients with high-grade atrioventricular block (AVB), a standard dual-chamber pacemaker can restore A-V synchrony and ensure an adequate ventricular pacing rate. In this setting, however, the ...

Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a ...

A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a ...

Patients with heart failure, serious atrioventricular nodal block and recurring atrial fibrillation who are treated with cardiac resynchronization therapy using traditional single-site ventricular ...

Heart failure is a fatal condition that can put a patient’s life at stake. Heart conditions are caused due to the ill-functioning of the heart due to various internal and lifestyle situations.

The Cardiac Resynchronization in Heart Failure (CARE-HF) [1] trial was an open-label, randomized, controlled study that evaluated the effects of cardiac resynchronization therapy (CRT) on morbidity ...

Background Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce ...

Heart failure remains a huge health care burden, with one in nine death certificates in the United States listing it as the cause of death. 1 Medical therapy has improved the prognosis for patients ...

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...

To the Editor: In the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT), Moss and colleagues (Oct. 1 issue) 1 enrolled minimally symptomatic ...